|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
10,650,000 |
Market
Cap: |
1.25(M) |
Last
Volume: |
1,291,850 |
Avg
Vol: |
1,288,294 |
52
Week Range: |
$0.1174 - $0.1174 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Perry Lee |
VP & Chief Accounting Officer |
|
2012-01-09 |
4 |
OE |
$2.95 |
$119,761 |
D/D |
39,700 |
14,700 |
|
- |
|
Day Wesley |
VP, Clinical Development |
|
2012-01-09 |
4 |
AS |
$11.50 |
$345,000 |
D/D |
(30,000) |
16,800 |
|
- |
|
Day Wesley |
VP, Clinical Development |
|
2012-01-09 |
4 |
OE |
$3.28 |
$98,400 |
D/D |
30,000 |
46,800 |
|
- |
|
Casamento Charles J |
Director |
|
2011-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
62,125 |
|
- |
|
Casamento Charles J |
Director |
|
2011-12-06 |
4 |
OE |
$4.23 |
$105,750 |
D/D |
25,000 |
25,000 |
|
- |
|
Day Wesley |
VP, Clinical Development |
|
2011-11-11 |
4 |
S |
$9.87 |
$231,349 |
D/D |
(23,442) |
16,800 |
|
- |
|
Day Wesley |
VP, Clinical Development |
|
2011-11-11 |
4 |
OE |
$3.13 |
$76,380 |
D/D |
23,442 |
40,242 |
|
- |
|
Tam Peter Y |
President |
|
2011-07-11 |
4 |
OE |
$3.40 |
$17,000 |
D/D |
5,000 |
135,621 |
|
- |
|
Day Wesley |
VP, Clinical Development |
|
2010-12-17 |
4/A |
S |
$9.54 |
$673,446 |
D/D |
(70,600) |
16,800 |
|
- |
|
Logan Mark B |
Director |
|
2010-12-17 |
4 |
S |
$9.52 |
$190,338 |
D/D |
(20,000) |
48,000 |
|
- |
|
Logan Mark B |
Director |
|
2010-12-17 |
4 |
OE |
$2.99 |
$73,380 |
D/D |
20,000 |
68,000 |
|
- |
|
Day Wesley |
VP, Clinical Development |
|
2010-12-17 |
4 |
S |
$9.54 |
$635,491 |
D/D |
(66,600) |
20,800 |
|
- |
|
Day Wesley |
VP, Clinical Development |
|
2010-12-17 |
4 |
OE |
$3.26 |
$195,600 |
D/D |
60,000 |
87,400 |
|
- |
|
Tam Peter Y |
President |
|
2010-12-16 |
4 |
S |
$9.28 |
$92,807 |
D/D |
(10,000) |
126,775 |
|
- |
|
Tam Peter Y |
President |
|
2010-12-16 |
4 |
OE |
$3.88 |
$72,656 |
D/D |
18,750 |
136,775 |
|
- |
|
Logan Mark B |
Director |
|
2010-12-15 |
4 |
S |
$9.14 |
$164,520 |
D/D |
(18,000) |
48,000 |
|
- |
|
Logan Mark B |
Director |
|
2010-12-15 |
4 |
OE |
$4.59 |
$103,180 |
D/D |
18,000 |
66,000 |
|
- |
|
Shortliffe Linda M Dairiki |
Director |
|
2010-12-15 |
4 |
S |
$9.31 |
$74,480 |
D/D |
(8,000) |
0 |
|
- |
|
Shortliffe Linda M Dairiki |
Director |
|
2010-12-15 |
4 |
OE |
$3.96 |
$31,680 |
D/D |
8,000 |
8,000 |
|
- |
|
Wilson Leland F |
Chief Executive Officer |
|
2010-12-15 |
4 |
S |
$9.16 |
$568,156 |
D/D |
(62,000) |
115,966 |
|
- |
|
Wilson Leland F |
Chief Executive Officer |
|
2010-12-15 |
4 |
OE |
$3.88 |
$387,500 |
D/D |
100,000 |
177,966 |
|
- |
|
Logan Mark B |
Director |
|
2010-07-22 |
4 |
OE |
$3.96 |
$31,680 |
D/D |
8,000 |
48,000 |
|
- |
|
Morris Timothy E |
SVP, Finance & CFO |
|
2010-06-14 |
4 |
AS |
$12.16 |
$319,289 |
D/D |
(26,250) |
0 |
|
- |
|
Morris Timothy E |
SVP, Finance & CFO |
|
2010-06-14 |
4 |
OE |
$3.13 |
$82,163 |
D/D |
26,250 |
26,250 |
|
- |
|
Wilson Leland F |
Chief Executive Officer |
|
2010-05-18 |
4 |
AS |
$13.00 |
$650,000 |
D/D |
(50,000) |
76,772 |
|
- |
|
555 Records found
|
|
Page 17 of 23 |
|
|